FDA: Yet Another Blood Pressure Medication Recall Due To Cancer Concerns

This time it ’s Lupin Pharmaceuticals Inc. recalling all batches of their irbesartan tablets as well as their irbesartan plus hydrochlorothiazide tablets.

Source: Forbes.com Healthcare News - October 24, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news